AAAAAA
Results: 1-25/33
Authors:
Kaiser, B
Hoppensteadt, DA
Fareed, J
Citation: B. Kaiser et al., Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders, EXPERT OP I, 10(11), 2001, pp. 1925-1935
Authors:
Kanabrocki, EL
George, M
Hermida, RC
Messmore, HL
Ryan, MD
Ayala, DE
Hoppensteadt, DA
Fareed, J
Bremner, FW
Third, JLHC
Shirazi, P
Nemchausky, BA
Citation: El. Kanabrocki et al., Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectin, CL APPL T-H, 7(4), 2001, pp. 339-345
Authors:
Cella, G
Sbarai, A
Mazzaro, G
Motta, G
Carraro, P
Andreozzi, GM
Hoppensteadt, DA
Fareed, J
Citation: G. Cella et al., Tissue factor pathway inhibitor release induced by defibrotide and heparins, CL APPL T-H, 7(3), 2001, pp. 225-228
Authors:
Demir, M
Iqbal, O
Hoppensteadt, DA
Piccolo, P
Ahmad, S
Schultz, CL
Linhardt, RJ
Fareed, J
Citation: M. Demir et al., Anticoagulant and antiprotease profiles of a novel natural heparinomimeticmannopentaose phosphate sulfate (PI-88), CL APPL T-H, 7(2), 2001, pp. 131-140
Authors:
Santillan, MKO
Herring, J
Hoppensteadt, DA
Jeske, W
Herbert, JM
Fareed, J
Citation: Mko. Santillan et al., The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys, CL APPL T-H, 7(1), 2001, pp. 10-15
Authors:
Demir, M
Iqbal, O
Untch, B
Hoppensteadt, DA
Gaikwad, BS
Fareed, J
Citation: M. Demir et al., Ecarin clotting time is sensitive to heparinoids: Comparison of two different techniques, CL APPL T-H, 7(1), 2001, pp. 38-43
Authors:
Demir, M
Iqbal, O
Dietrich, CP
Hoppensteadt, DA
Ahmad, S
Daud, AN
Fareed, J
Citation: M. Demir et al., Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I, CL APPL T-H, 7(1), 2001, pp. 44-52
Authors:
Hakki, SI
Fareed, J
Hoppensteadt, DA
Abdullah, H
Camblin, J
Nasseri, AF
Hamadeh, O
Wright, T
Citation: Si. Hakki et al., Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery (vol 6, pg 206, 2000), CL APPL T-H, 7(1), 2001, pp. 64-71
Authors:
Hoppensteadt, DA
Fareed, J
Raake, P
Raake, W
Citation: Da. Hoppensteadt et al., Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates, THROMB RES, 103(2), 2001, pp. 157-163
Authors:
Fareed, J
Shaikh, T
Hoppensteadt, DA
Citation: J. Fareed et al., Antithrombin and anti-Xa agents in the control of thrombogenesis, PHARMAZIE, 56, 2001, pp. S12-S21
Authors:
Fareed, J
Hoppensteadt, DA
Bacher, P
Messmore, HL
Citation: J. Fareed et al., Antithrombin agents: The new class of antithrombotic drugs, EVIDENCE-BASED MANAGEMENT OF THE ACUTE CORONARY SYNDROME, 2001, pp. 131-146
Authors:
Iqbal, O
Demir, AM
Hoppensteadt, DA
Wehrmacher, WH
Messmore, HL
Fareed, J
Citation: O. Iqbal et al., Thrombolytic therapy in acute coronary syndrome, EVIDENCE-BASED MANAGEMENT OF THE ACUTE CORONARY SYNDROME, 2001, pp. 147-166
Authors:
Gerbutavicius, R
Iqbal, O
Messmore, H
Hoppensteadt, DA
Demir, M
Khan, E
Bacher, P
Fareed, J
Citation: R. Gerbutavicius et al., Differential effects of unfractionated heparin and low-molecular-weight heparins on tissue thromboplastin inhibition test, CL APPL T-H, 6(4), 2000, pp. 190-196
Authors:
Hakki, SI
Fareed, J
Hoppensteadt, DA
Abdullah, H
Camblin, J
Nasseri, AF
Hamadeh, O
Wright, T
Citation: Si. Hakki et al., Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery, CL APPL T-H, 6(4), 2000, pp. 206-212
Authors:
Amin, HM
Ahmad, S
Walenga, JM
Hoppensteadt, DA
Leitz, H
Fareed, J
Citation: Hm. Amin et al., Soluble P-selectin in human plasma: Effect of anticoagulant matrix and itslevels in patients with cardiovascular disorders, CL APPL T-H, 6(2), 2000, pp. 71-76
Authors:
Ahmad, S
Yang, LH
Ahsan, A
Fu, K
Iqbal, O
Hoppensteadt, DA
Lewis, BE
Walenga, JM
Fareed, J
Citation: S. Ahmad et al., Pharmacokinetics of argatroban in primates: Evidence on endogenous uptake, INT ANGIOL, 19(2), 2000, pp. 126-134
Authors:
Kanabrocki, EL
Third, JLHC
Ryan, MD
Nemchausky, BA
Shirazi, P
Scheving, LE
McCormick, JB
Hermida, RC
Bremner, WF
Hoppensteadt, DA
Fareed, J
Olwin, JH
Citation: El. Kanabrocki et al., Circadian relationship of serum uric acid and nitric oxide, J AM MED A, 283(17), 2000, pp. 2240-2241
Authors:
Izban, KF
Lietz, HW
Hoppensteadt, DA
Jeske, WP
Fareed, J
Bakhos, M
Walenga, JM
Citation: Kf. Izban et al., Letter to the editor - The authors' response, SEM THROMB, 26(4), 2000, pp. 440-440
Authors:
Fareed, J
Hoppensteadt, DA
Bick, RL
Citation: J. Fareed et al., An update on heparins at the beginning of the new millennium, SEM THROMB, 26, 2000, pp. 5-21
Authors:
Fareed, J
Hoppensteadt, DA
Citation: J. Fareed et Da. Hoppensteadt, Heparins in the new millennium: Will unfractionated heparin survive? Epilogue, SEM THROMB, 26, 2000, pp. 87-88
Authors:
Jeske, W
Hoppensteadt, DA
Pifarre, R
Walenga, JM
Fareed, J
Citation: W. Jeske et al., Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy, ACUTE PULMONARY EMBOLISM, 2000, pp. 95-122
Authors:
Ahmad, S
Jeske, WP
Walenga, JM
Hoppensteadt, DA
Wood, JJ
Herbert, JM
Messmore, HL
Fareed, J
Citation: S. Ahmad et al., Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies, CL APPL T-H, 5(4), 1999, pp. 259-266
Authors:
Fareed, J
Hoppensteadt, DA
Leya, F
Lewis, B
Callas, D
Wolf, H
Bick, RL
Citation: J. Fareed et al., Thrombogenesis in myocardial infarction and related syndromes: The role ofmolecular markers in diagnosis and management, CL APPL T-H, 5(2), 1999, pp. 78-91
Authors:
Fareed, J
Walenga, JM
Hoppensteadt, DA
Jeske, WP
Ahmad, S
Lietz, H
McKenna, R
Messmore, HL
Haas, S
Citation: J. Fareed et al., Soluble adhesion molecules in the HIT syndrome: Pathophysiologic role and therapeutic modulation, CL APPL T-H, 5, 1999, pp. S38-S44
Authors:
Fareed, J
Lewis, BE
Callas, DD
Hoppensteadt, DA
Walenga, JM
Bick, RL
Citation: J. Fareed et al., Antithrombin agents: The new class of anticoagulant and antithrombotic drugs, CL APPL T-H, 5, 1999, pp. S45-S55